Table 2. Characterisation of PLGA NPs for in vivo validation.
Mean ± s.e.m (n=3); measured in deionised water (dH2O).
| NP formulation | Size (nm) | PDI | Zeta potential (mV) | CPT loading (μg/mg) | CTX conjugation (μg/mg) | IgG conjugation (μg/mg) |
|---|---|---|---|---|---|---|
| Blank-NP | 204.76 ±6.3 | 0.12 ±0.025 | −25.8 ±3.78 | NA | NA | NA |
| IgG1-NP | 240.8 ±5.93 | 0.132 ±0.04 | −26.01 ±0.07 | NA | NA | 26.1 ±2.3 |
| CPT-NP | 208.4 ±4.96 | 0.135 ±0.02 | −19.68 ±1.31 | 19.8 ±1.5 | NA | NA |
| CTX-CPT-NP | 214.91 ±4.96 | 0.157 ±0.02 | −21.18 ±0.55 | 19.4 ±1 | 35.7 ±6.0 | NA |